These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8604495)

  • 1. Current good manufacturing practices.
    Zuck TF
    Transfusion; 1995; 35(11):955-66. PubMed ID: 8604495
    [No Abstract]   [Full Text] [Related]  

  • 2. Application of good manufacturing practice regulations to investigational biologic products.
    Goebel PW
    J Parenter Drug Assoc; 1980; 34(5):348-51. PubMed ID: 6905865
    [No Abstract]   [Full Text] [Related]  

  • 3. Safety monitoring and epidemiological surveillance of blood transfusion in the United States.
    Menache D; O'Malley JP
    Transfus Clin Biol; 1995; 2(1):7-12. PubMed ID: 7728271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Food and Drug Administration regulations and licensure.
    Barker LF
    Fed Proc; 1975 May; 34(6):1522-4. PubMed ID: 1126452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 100 years of biologics regulation.
    FDA Consum; 2002; 36(4):8-10. PubMed ID: 12184315
    [No Abstract]   [Full Text] [Related]  

  • 6. Biosimilars legislation awakens data exclusivity debate.
    Hutson S
    Nat Med; 2009 Nov; 15(11):1242. PubMed ID: 19893548
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of biologics by food animal practitioners.
    Herrick JB
    J Am Vet Med Assoc; 1990 Jun; 196(12):1937. PubMed ID: 2365615
    [No Abstract]   [Full Text] [Related]  

  • 8. Regulatory watch: Innovation in biologic new molecular entities: 1986-2014.
    Miller KL; Lanthier M
    Nat Rev Drug Discov; 2015 Feb; 14(2):83. PubMed ID: 25633785
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological products: reporting of biological product deviations in manufacturing. Food and Drug Administration, HHS. Final rule.
    Fed Regist; 2000 Nov; 65(216):66621-35. PubMed ID: 11503696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. International Conference on Harmonisation; guidance on Q5E Comparability of Biotechnological/Biological Products Subject to Changes in Their Manufacturing Process; availability. Notice.
    Food and Drug Administration, HHS
    Fed Regist; 2005 Jun; 70(125):37861-2. PubMed ID: 15988855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential use of the scan statistic for quality control in blood product manufacturing.
    Lachenbruch PA; Foulkes MA; Williams AE; Epstein JS
    J Biopharm Stat; 2005; 15(2):353-66. PubMed ID: 15796300
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Food and Drug Administration and the backward motion toward the source.
    Kennedy D
    Public Health Rep; 1978; 93(6):607-15. PubMed ID: 362468
    [No Abstract]   [Full Text] [Related]  

  • 13. Quality control and good manufacturing practices: safety and efficacy of commercial herbals.
    Awang DV
    Food Drug Law J; 1997; 52(3):341-4. PubMed ID: 10343036
    [No Abstract]   [Full Text] [Related]  

  • 14. Blood safety. The Food and Drug Administration's role.
    Gustafson M
    Arch Pathol Lab Med; 1999 Jun; 123(6):475-7. PubMed ID: 10383796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The road to the biotech revolution: highlights of 100 years of biologics regulation.
    Bren L
    FDA Consum; 2006; 40(1):50-7. PubMed ID: 16528828
    [No Abstract]   [Full Text] [Related]  

  • 16. Blood safety proposals.
    Oncology (Williston Park); 1994 Jun; 8(6):57-8. PubMed ID: 8074984
    [No Abstract]   [Full Text] [Related]  

  • 17. Design and operation of a current good manufacturing practices cell-engineering laboratory.
    Burger SR
    Cytotherapy; 2000; 2(2):111-22. PubMed ID: 12042048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Control of manufacture--principles and purposes.
    Luff PR
    Dev Biol Stand; 1992; 79():155-8. PubMed ID: 1286749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliance with Good Manufacturing Practices for facilities engaged in vector production, cell isolation, and genetic manipulations.
    Steel MP; Roessler BJ
    Curr Opin Biotechnol; 1999 Jun; 10(3):295-7. PubMed ID: 10361080
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety aspects of blood transfusion and European legislation.
    Koistinen JL
    Hematol J; 2004; 5 Suppl 3():S83-6. PubMed ID: 15190284
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.